Edgewise Therapeutics (EWTX) Debt to Equity (2022)
Edgewise Therapeutics has reported Debt to Equity over the past 1 years, most recently at $0.0 for Q3 2022.
Edgewise Therapeutics has reported Debt to Equity over the past 1 years, most recently at $0.0 for Q3 2022.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month